Linked Life Data

18456188

Source:http://linkedlifedata.com/resource/pubmed/id/18456188

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2008-5-5
pubmed:abstractText
Osteoporosis, characterized by loss of bone strength leading to fragility fractures, is a common event in patients who have primary biliary cirrhosis. Although its pathogenesis is not well known, it results mainly from low bone formation. There is no specific treatment, but bisphosphonates, especially alendronate, effectively increases bone mass and prevents bone loss. Despite these favorable effects on bone mass, no clear effects on decreasing the fracture rate are demonstrated, probably because of the low number of patients included in the trials. The potential usefulness of new agents requires further evaluation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1089-3261
pubmed:author
pubmed:issnType
Print
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
407-24; x
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Osteoporosis in primary biliary cirrhosis: pathogenesis and treatment.
pubmed:affiliation
Liver Unit, Institute of Digestive Diseases, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi Sunyer, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Barcelona, Spain. pares@ub.edu <pares@ub.edu>
pubmed:publicationType
Journal Article, Review